Delivery Order SPE2DB22D3501-SPE2DB25FWG85
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The contract has a ceiling value of $26,285.85 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating it was competed on an unrestricted basis. The contract has...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a ceiling value of $52,571.70 and a period of performance extending until May 29, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML. The contract has a ceiling value of $26,285.85 and an ultimate completion date of July 29, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $26,285.85 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The contract has a performance period through June 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a firm fixed price, with a potential value of $125,000.72, and a completion date of January 25, 2024. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. This delivery order is not...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,285.93 firm fixed-price contract is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a prescription medication. The contract has an ultimate completion date of May 1, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty medication, with a ceiling value of $98,390.78. The contract is a Firm Fixed Price type, with an ultimate completion date of October 3, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $51,070.20, is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 20, 2024. The contract was not designated with any set-aside requirements, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The contract has a ceiling value of $93,538.86 and an ultimate completion date of February 21, 2023. This contract is not designated as a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,826.19, is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a period of performance running through November 20, 2024. The contract is not designated as a set-aside and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWG85Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a ceiling value of $26,285.85 and is a firm fixed price contract. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp also holds a large $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This positions the company as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.3k | 7/7/25 |